Although multiple studies have reported PDK activity in malignancy and its association with chemotherapeutic resistance [122], including in bladder cancer [27,123,124,125], no study (to the best of our knowledge) has examined the association between PDH expression and the clinical/prognostic factors associated with UBC. The gene discussed is PDP1; the disease is urinary bladder carcinoma.